Mitogen-activated protein kinase
FunctionMitogen-activated protein kinase (MAPK) also known as Extracellular Signal-Regulated Kinase (ERK) are serine/threonine kinases which regulate various cellular activities in response to extracellular stimuli by mitogens, heat shock and more. MAPK is part of the MAPK cascade which consists of MAPK, MAP2K and MAP3K which are activated by phosphorylation[1].
RelevanceMAPK cascade is elevated in cancer cells, hence MAPK inhibitors are tested as potential cancer therapy. DiseaseMAPK14 is associated with acquired hyperkeratosis and prostate transitional cell carcinoma. Structural highlights[2]. Water molecule shown as red sphere. |
|
3D Structures of Mitogen-activated protein kinase3D Structures of Mitogen-activated protein kinase
Updated on 23-July-2017
- MAPK8
- 3o17, 2gmx, 2g01, 3vud, 3vug, 3vuh, 3vui, 3vuk, 3vul, 3vum – hMAPK8 (mutant)+JIP1 peptide
- 1ukh, 1uki - jMAPK8 JNK1+JIP1 peptide
- 3v3v - hMAPK8 JNK1+JIP1 peptide + quercedagetin
- 3o2m - hMAPK8 (mutant)+JIP1 peptide+biaryl tetrazole
- 2xrw, 2xs0 - hMAPK8 + NFAT peptide
- 4ux9 – hMAPK8 + MAPKK7 peptide
- 4yr8 – hMAPK8 + MKP7
- 3elj, 3pze, 4awi, 4l7f, 4qtd - hMAPK8+inhibitor
- 4e73, 4g1w, 4hys, 4hyu, 4izy – hMAPK8 + JIP1 +inhibitor
- 2no3, 2h96 – hMAPK8 (mutant)+inhibitor
- 3o17, 2gmx, 2g01, 3vud, 3vug, 3vuh, 3vui, 3vuk, 3vul, 3vum – hMAPK8 (mutant)+JIP1 peptide
- MAPK9
- MAPK10
- 3kvx, 3fv8, 2waj, 3fi2, 3fi3, 3da6, 2zdt, 2zdu, 3cgf, 3cgo, 2r9s, 2o0u, 2o2u, 2exc, 2b1p, 1pmn, 4z9l, 1pmu, 1pmv, 3oy1, 2ok1, 3ttj, 3tti, 3rtp, 3v6r, 3v6s, 4kkh, 4u79, 4whz, 4x21, 4y46, 4y5h – hMAPK10+inhibitor
- 3ptg, 4h39 - hMAPK10 catalytic domain + JIP1 peptide
- 4h36 – hMAPK10 catalytic domain + ATF2 peptide
- 4h3b – hMAPK10 catalytic domain + SAB peptide
- 4kke, 4kkg – hMAPK10 catalytic domain + AMPPNP
- 3g9l, 3g90, 3g9n, 2p33 – hMAPK10 catalytic domain+inhibitor
- 3oxi - hMAPK10 + MAPK8 interacting protein + inhibitor
- 3kvx, 3fv8, 2waj, 3fi2, 3fi3, 3da6, 2zdt, 2zdu, 3cgf, 3cgo, 2r9s, 2o0u, 2o2u, 2exc, 2b1p, 1pmn, 4z9l, 1pmu, 1pmv, 3oy1, 2ok1, 3ttj, 3tti, 3rtp, 3v6r, 3v6s, 4kkh, 4u79, 4whz, 4x21, 4y46, 4y5h – hMAPK10+inhibitor
- MAPK11
- MAPK13
- MAPK14
- 3mgy, 3mh0, 3mh1, 3mh2, 3mh3, 3hvc, 3npq, 1wbo, 1r39, 2npq, 1wfc, 1cm8, 5etc, 5eti, 5uoj – hMAPK14
- 2lgc – hMAPK14 – NMR
- 3od6, 3ody, 3odz, 3oef, 3p4k, 2fsl, 2fsm, 2fso, 2fst, 1r3c, 4e5a, 4geo – hMAPK14 (mutant)
- 3new, 3ocg, 3mvl, 3mvm, 3nnu, 3nnv, 3nnw, 3nnx, 3nww, 3mpt, 3lhj, 3huc, 3itz, 3l8x, 3kf7, 3fi4, 3fkl, 3fkn, 3fko, 3fl4, 3fln, 3flq, 3fls, 3flw, 3fly, 3flz, 3fmh, 3fmj, 3fmk, 3fml, 3flm, 3fln, 3fsf, 3fsk, 3kq7, 3iph, 3hv4, 3hv5, 3hv6, 3hv7, 3k3i, 3hec, 3heg, 3gi3, 3hp2, 3hp5, 3hrb, 3ha8, 3gfe, 3hl7, 3hll, 3gcu, 3fc1, 3dt1, 3e92, 3e93, 3d7z, 3d83, 3ctq, 2puu, 3bx5, 3c5u, 2zaz, 2zb0, 2zb1, 2qd9, 2ewa, 2gfs, 2baj, 2bak, 2bal, 2baq, 1zyj, 1wbn, 1wbs, 1wbt, 1wbv, 1wbw, 1zz2, 1zzl, 1yqj, 1w7h, 1w82, 1w83, 1w84, 1oz1, 1ouk, 1ouy, 1m7q, 1kv1, 1kv2, 1di9, 2rg5, 2rg6, 3bv3, 3bv2, 3fmm, 3fmn, 3lfa, 3mw1, 3pg3, 3roc ,2yis, 2yiw, 2yix, 3qud, 3que, 3rin, 3s3i, 3s4q, 3u8w, 3uvp, 3uvq, 3uvr, 3zs5, 3zsg, 3zsh, 3zsi, 3zya, 4a9y, 4aa0, 4aa4, 4aa5, 4aac, 4dli, 4dlj, 4e5b, 4eh2, 4eh3, 4eh4, 4eh5, 4eh6, 4eh7, 4eh8, 4eh9, 4ehv, 4ewq, 4f9w, 4f9y, 4fa2, 4kin, 4kip, 4kiq, 4l8m, 4r3c, 4zth, 5lar, 5ml5, 5tbe, 5tco - hMAPK14+inhibitor
- 4e6a, 4e6c, 4e8a - hMAPK14+ lipid
- 3o8t, 3mpa, 3obg, 3o8u, 3o8p, 3obj, 3oc1, 3hub, 3l8s, 3hv3, 3iw5, 3iw6, 3iw7, 3iw8, 3k3j, 3gc7, 3gcp, 3gcq, 3gcs, 3gcv, 3ds6, 2i0h, 1ove, 3lfb, 3lfc, 3lfd, 3lfe, 3lff, 1bl6, 1bl7, 1bmk, 1a9u, 1ian - hMAPK14 (mutant)+inhibitor
- 2y8o – hMAPK14 (mutant) + dual specificity MAP2K peptide
- 4ka3, 4loo, 4lop, 4loq – hMAPK14 + docking peptide
- 5eta – hMAPK14 + peptide
- 3tg1 – hMAPK14 + MAPK phosphatase 5
- 5etf – hMAPK14 + MAPKK 6
- 2gtn, 2gtm, 3p5k, 3p78, 3p79, 3p7a, 3p7b, 3p7c - mMAPK14+inhibitor
- 2ghm, 2ghl, 1ywr - mMAPK14 (mutant)+inhibitor
- 3py3 - mMAPK14 phosphorylated
- 1yw2, 1p38 - mMAPK14 (mutant)
- 1lew - mMAPK14+MEF2A
- 1lez - mMAPK14+MKK3B
- 3mgy, 3mh0, 3mh1, 3mh2, 3mh3, 3hvc, 3npq, 1wbo, 1r39, 2npq, 1wfc, 1cm8, 5etc, 5eti, 5uoj – hMAPK14
- MAPK Fus3
- MAPK
ReferencesReferences
- ↑ Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol. 1997 Apr;9(2):180-6. PMID:9069255
- ↑ Aronov AM, Baker C, Bemis GW, Cao J, Chen G, Ford PJ, Germann UA, Green J, Hale MR, Jacobs M, Janetka JW, Maltais F, Martinez-Botella G, Namchuk MN, Straub J, Tang Q, Xie X. Flipped out: structure-guided design of selective pyrazolylpyrrole ERK inhibitors. J Med Chem. 2007 Mar 22;50(6):1280-7. Epub 2007 Feb 15. PMID:17300186 doi:http://dx.doi.org/10.1021/jm061381f